Antony Loebel

Antony Loebel is currently Director at Pharmaceutical Research & Manufacturers of America, Director at Sunovion Pharmaceuticals Europe Ltd. since 2019, Director at HighCape Capital Acquisition Corp.
II, Assistant Professor at New York University School of Medicine, Advisor at HighCape Partners Management LLC, and Chief Medical Officer at Seaport Therapeutics, Inc. since 2024.
Former positions include Director at Pfizer Inc. from 2006 to 2007, Director, Chief Medical Officer & Executive VP at Sumitomo Pharma America, Inc. from 2007 to 2019, Director at Massachusetts Biotechnology Council, and Independent Director at HighCape Capital Acquisition Corp.
from 2020 to 2021.
Education includes undergraduate studies at the University of Washington and a doctorate from UW Medicine.